Results 251 to 260 of about 5,260,545 (402)
Engineering of Erythrocytes as Drug Carriers for Therapeutic Applications [PDF]
Baoshuo Jia +5 more
openalex +1 more source
Metformin mediates mitochondrial quality control in Leber's hereditary optic neuropathy (LHON) fibroblasts carrying mtDNA mutations. At therapeutic levels, metformin activates AMPK signaling to restore mitochondrial dynamics by promoting fusion and restraining fission, while preserving mitochondrial mass, enhancing autophagy/mitophagy and biogenesis ...
Chatnapa Panusatid +3 more
wiley +1 more source
Stability and Rheological Properties of the Novel Silica-Based Organogel-A Drug Carrier with High Solubilization Potential. [PDF]
Suwiński G, Nowak I.
europepmc +1 more source
Self-Assembling Hybrid Linear-Dendritic Block Copolymers: The Design of Nano-Carriers for Lipophilic Antitumoral Drugs [PDF]
Elisabetta Fedeli +5 more
openalex +1 more source
We investigated the toxicity of 12 active compounds commonly found in herbal weight loss supplements (WLS) using human liver and colon cell models. Epigallocatechin‐3‐gallate was the only compound showing significant toxicity. Metabolic profiling revealed protein degradation, disrupted energy and lipid metabolism suggesting that the inclusion of EGCG ...
Emily C. Davies +3 more
wiley +1 more source
Modified diatom-based ocular suspension for sustained diclofenac sodium delivery: a novel drug carrier approach. [PDF]
Ghasemishayan R, Jalaei D, Dobakhti F.
europepmc +1 more source
Drug Delivery: Remotely Controlled Red Blood Cell Carriers for Cancer Targeting and Near‐Infrared Light‐Triggered Drug Release in Combined Photothermal–Chemotherapy (Adv. Funct. Mater. 16/2015) [PDF]
Xiaoqi Sun +4 more
openalex +1 more source
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point +7 more
wiley +1 more source

